TEST 25-26

The chart shows the growth of an initial investment of $10,000 in TEST 25-26, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

Based on dividend-adjusted daily data since Jul 31, 2018, TEST 25-26's average daily return is +0.17%, while the average monthly return is +3.53%. At this rate, your investment would double in approximately 1.7 years.

Historically, 62% of months were positive and 38% were negative. The best month was Nov 2020 with a return of +30.6%, while the worst month was Mar 2020 at -24.1%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 3 months.

On a daily basis, TEST 25-26 closed higher 55% of trading days. The best single day was Apr 9, 2025 with a return of +15.0%, while the worst single day was Mar 16, 2020 at -14.1%.

TEST 25-26 has an annualized alpha of 28.05%, beta of 1.41, and R² of 0.62 versus S&P 500 Index. Calculated based on daily prices since July 31, 2018.

• This portfolio captured 244.45% of S&P 500 Index gains and 108.77% of its losses — amplifying both gains and losses, but participating more in upside than downside.
• This portfolio generated an annualized alpha of 28.05% versus S&P 500 Index — delivering returns beyond what market exposure alone would predict.

TEST 25-26 has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

TEST 25-26 ranks 99 for risk / return — in the top 99% of portfolios on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

TEST 25-26 Sharpe ratios as of Apr 4, 2026 (values are recalculated daily):

• 1-Year: 5.69
• 5-Year: 1.69
• All Time: 1.27

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 0.99 to 1.69, this portfolio's current Sharpe ratio is in the top 25%. This signifies superior risk-adjusted performance, meaning the portfolio is delivering strong returns for the level of risk taken compared to most others.

The chart below shows the rolling Sharpe ratio of TEST 25-26 compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

TEST 25-26 provided a 0.23% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the TEST 25-26. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the TEST 25-26 was 46.39%, occurring on Mar 18, 2020. Recovery took 164 trading sessions.

The current TEST 25-26 drawdown is 3.13%.

The chart below shows the rolling one-month volatility.